Product Information
SAGE-217 is a novel antidepressant drug that has been shown to be effective in the treatment of depression. The drug is orally administered and is rapidly absorbed, with peak plasma concentrations occurring within one hour. It binds to GABA receptors and blocks the binding of the neurotransmitter gamma-aminobutyric acid (GABA) to its receptor, which reduces brain activity and has an anti-anxiety effect. SAGE-217 may also have other effects on neurotransmitters, such as serotonin or dopamine, but this remains unclear.
Chemical properties
Technical inquiry about: 3D-HQC05140 SAGE-217
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
